quote:Originally posted by 10of13: We'll do..you keep your mind on the road...not the stock...LOL
Glad I'm not driving.....
-------------------- Anyone who lives within their means suffers from a lack of imagination.- Oscar Wilde Posts: 90 | Registered: Jun 2006
| IP: Logged |
quote:Originally posted by Leslie C: I can't believe I'm gonna be on the road for 4 hours today and miss all the action! I'm giddy with excitment. Ya'll hold the rope for me.
If you can, buy a laptop/air-card with your profits!!! I travel everywhere and it keeps me trading Even though the cops stop every once in a while and ask what the hell you are doing on the side of the road.
quote:Originally posted by Leslie C: I can't believe I'm gonna be on the road for 4 hours today and miss all the action! I'm giddy with excitment. Ya'll hold the rope for me.
Have a safe trip.
-------------------- Buy Low. Sell High. Posts: 10750 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
quote:Originally posted by Leslie C: I can't believe I'm gonna be on the road for 4 hours today and miss all the action! I'm giddy with excitment. Ya'll hold the rope for me.
If you can, buy a laptop/air-card with your profits!!! I travel everywhere and it keeps me trading Even though the cops stop every once in a while and ask what the hell you are doing on the side of the road.
That's funny. I've had the same thing happen to me a few times. I just ask them if it would be better for me to drive while I'm working.
Posts: 2132 | Registered: Sep 2004
| IP: Logged |
quote:Originally posted by Peaser01: Looking like a possible bounce here from .1045
Yep!
-------------------- E440 I won't be responsible for any losses resulting from anyone using my posts as part of their DD. Posts: 255 | From: South Florida | Registered: May 2006
| IP: Logged |
quote:Originally posted by amswap: That's funny. I've had the same thing happen to me a few times. I just ask them if it would be better for me to drive while I'm working.
ROFL
-------------------- Buy Low. Sell High. Posts: 10750 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
posted
2 things from pink sheets...if these have been posted...sorry...
WallStreetGrapevine.com: "Stocks on the Rise- INTK, XKEM, AOGS"
Jul 05, 2006 (M2 PRESSWIRE via COMTEX) -- Wall Street, NYC-Today, wallstreetgrapevine.com, named; Industrial Nanotech Inc. (Pink Sheets: INTK), Xechem International Inc. (OTC BB: XKEM), and Avalon Oil & Gas Inc. (OTC BB: AOGS); their "Stocks on the Rise." Industrial Nanotech Inc. (Pink Sheets: INTK, http://www.marketwatch.com/tools/quotes/quotes.asp?symb=intk&vc=&siteid= mktw&dist=dropmenu)
TalkingStocks.com Announces Profile Coverage of Industrial Nanotech
Saleem Hijazy of TalkingStocks.com announced today that the web site has initiated Profile Coverage of Industrial Nanotech Inc. (Pink Sheets:INTK). Industrial Nanotech is a public company traded on the Pink Sheets under the symbol INTK. The company was created in 2004 in order to capitalize on new opportunities that were emerging out of the nanotechnology sector.
Industrial Nanotech today is a product-focused technology company that is applying the latest discoveries in nanoscience to the development of proprietary products and materials. These advances will eventually impact virtually every walk of life, from improved industrial capacity and profits, to life saving safety features and potentially, revolutionary new approaches.
As the basis for its product development, Industrial Nanotech holds the exclusive worldwide rights to patented technologies developed by the current CEO and founder of the company. The Company also continues to develop new technologies utilizing the resources of major national and private laboratories.
Industrial Nanotech has developed and is now bringing to market radically improved products that deal with the costly problems of heat and energy loss, corrosion under conventional thermal insulation, and the negative health impacts of mold growth and lead in residential and industrial facilities. The products, trademarked under the brand name Nansulate(tm), are sold worldwide.
TalkingStocks.com is a leading destination for those seeking information on small cap and microcap companies. The website feature companies in Profile Campaigns, Key Executive Interviews, email alerts and special reports authored by our financial writers. The web site set the standard for communication with investors. To feature a company or to get more information, please contact Saleem Hijazy for more information (Telephone: 469-252-3031; Email: Saleem*talkingstocks.com).
Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF
Xechem International, Inc. Xechem International announced today that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Drug Products Development, for the five-membered heterocyclic anti-sickling compound known as 5-HMF for the treatment of patients suffering from sickle cell disease (SCD).
Research led by Dr. Donald Abraham of Virginia Commonwealth University (VCU) has shown 5-HMF to be "the best potential anti-sickling agent in 30 years of sickle cell research", performed by his group. 5-HMF not only is a natural product with very little, if any, toxicity, but it has a high affinity for sickle cell hemoglobin. It is also very active in genetically modified mice as shown by Dr. Toshio Asakura, Director, and his colleagues at the NIH-NHLBI Sickle Cell Disease Reference Laboratory at the Children's Hospital of Philadelphia, University of Pennsylvania.
According to Xechem's Chairman and CEO, Dr. Ramesh Pandey, "We are pleased with the FDA's decision granting Orphan Drug Designation to 5-HMF. This puts Xechem into a unique position where the company will have two drugs in the pipeline for treating patients with sickle cell disease. 5-HMF is a new type of drug that interacts specifically with intracellular hemoglobin without interacting with other proteins in the body. Today there are no non-toxic drugs available on the market to treat SCD. We are actively proceeding with our first drug (NICOSAN(TM)) in the hope of bringing it to the Nigerian market immediately following Nigerian regulatory approval. We are also preparing the Investigational New Drug (IND) application for 5-HMF for submission to the FDA in the coming months." About Orphan Drug Designation Orphan Drug status entitles a company to various incentives including the waiver of Regulatory Filing fees, access to potential grant funding for non-clinical and clinical research to generate required data for marketing approval, and seven years of marketing exclusivity for a designated drug once approved by the FDA. (Orphan diseases are generally defined as those afflicting less than 200,000 people in the US.) About Sickle Cell Disease Sickle cell disease is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with this disease often produce stiff, abnormally shaped red blood cells that sometimes do not flow freely through blood vessels. This can create clogs in the vessels, which in turn cuts off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks, damage to various organs, and shortened life span. In the US, there are approximately 70-80,000 patients suffering with sickle cell disease, many of whom suffer unpredictable painful crises several times a year lasting a few hours to a week or more. In Nigeria, more than 4 million persons have the disease. Worldwide, approximately 12 million are believed to suffer from this disease.
About Xechem
Xechem International, Inc. is a development stage biopharmaceutical company whose focus and resources are currently being primarily directed toward the development and commercial launch of NICOSAN(TM) (to be marketed as HEMOXIN(TM) in the United States and Europe), which has shown efficacy in the prophylaxis management of Sickle Cell Disease (SCD). In addition to NICOSAN(TM) and 5-HMF, Xechem is also working on anticancer, antiviral (including AIDS), antifungal, antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its focus is on the development of phyto-pharmaceuticals (Natural Herbal Drugs) and other proprietary technologies, including those used in the treatment of orphan diseases.
AND
XKEM -- Xechem International, Inc. Com ($0.00001)(New)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Rochester, NY, Jul 05, 2006 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Cambodian Ventures Limited ( Pink Sheets: CMBV ), Xechem International, Inc. ( OTCBB: XKEM ), IDS Worldwide, Inc. ( Pink Sheets: IDWD ), CalbaTech, Inc. ( OTCBB: CLBE ). Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
Cambodian Ventures Limited ( Pink Sheets: CMBV.PK - http://finance.yahoo.com/q?s=CMBV.PK ) Cambodian Ventures Limited is pleased to announce that the Company is making significant progress towards signing a definitive joint venture agreement with TTY Corporation of Cambodia to develop two gold mining properties in Kratie Province, Kingdom of Cambodia.
Mr. Gary J. Fineberg, President of Cambodian Ventures, accompanied by Mr. Trevor Burns, President of Tiger Capital, recently met with the President of TTY Corporation to discuss the next steps to be taken to develop TTY's gold properties. Mr. Fineberg and Mr. Burns also had the opportunity to tour TTY's facilities and operations and tour the mining sites.
"I am very pleased with the way discussions are proceeding with TTY. Both parties are keen to move forward as rapidly as possible. We are presently making arrangements to have a geologist come to Cambodia to prepare a feasibility report on both sites. Once the report is completed and assuming it is favorable, I am confident that a joint venture agreement will be consummated shortly thereafter," stated Mr. Fineberg.
"I am impressed with TTY's businesses and the gold sites. TTY is a very substantial company in Cambodia in the areas of agriculture and mining. The two gold sites are both easily accessible by roads and both show a history of mining activity," stated Mr. Burns.
"I am pleased to learn while here that Cambodian Ventures has several other exciting opportunities to explore. Furthermore, a large Australian mining company is now preparing to make a significant investment in six other gold properties in Cambodia, validating Cambodian Ventures' belief that tremendous mining opportunities exist in this country," added Mr. Burns.
About Cambodian Ventures
The mission of Cambodian Ventures Limited is to obtain licenses for the exploration and mining of precious minerals in Cambodia. The Company intends to carry out exploration activities in regions containing gold and other precious minerals. It is Management's opinion that high-quality minerals such as gold, zinc and other resources in Cambodia are largely untapped and that a significant opportunity exists for their development.
Xechem International, Inc. ( OTCBB: XKEM - http://finance.yahoo.com/q?s=XKEM.OB ) Xechem International, Inc. announced that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Drug Products Development, for the five-membered heterocyclic anti-sickling compound known as 5-HMF for the treatment of patients suffering from sickle cell disease (SCD).
Research led by Dr. Donald Abraham of Virginia Commonwealth University (VCU) has shown 5-HMF to be "the best potential anti-sickling agent in 30 years of sickle cell research", performed by his group. 5-HMF not only is a natural product with very little, if any, toxicity, but it has a high affinity for sickle cell hemoglobin. It is also very active in genetically modified mice as shown by Dr. Toshio Asakura, Director, and his colleagues at the NIH-NHLBI Sickle Cell Disease Reference Laboratory at the Children's Hospital of Philadelphia, University of Pennsylvania.
According to Xechem's Chairman and CEO, Dr. Ramesh Pandey, "We are pleased with the FDA's decision granting Orphan Drug Designation to 5-HMF. This puts Xechem into a unique position where the company will have two drugs in the pipeline for treating patients with sickle cell disease. 5-HMF is a new type of drug that interacts specifically with intracellular hemoglobin without interacting with other proteins in the body. Today there are no non-toxic drugs available on the market to treat SCD. We are actively proceeding with our first drug (NICOSAN(TM)) in the hope of bringing it to the Nigerian market immediately following Nigerian regulatory approval. We are also preparing the Investigational New Drug (IND) application for 5-HMF for submission to the FDA in the coming months."
-------------------- #1 Rule: Protect your capital! #2 Rule: Never fall for the BS on the boards! Posts: 8890 | Registered: Jan 2006
| IP: Logged |
posted
Looks like Berlin is back in line following the US. Latest trade was at .085 which is .108 usd.
Posts: 176 | From: Ohio | Registered: Sep 2005
| IP: Logged |
quote:Originally posted by SherriT: So are we staying here or are we moving to the .11 and up?
AH--HA!!!! You guys couldn't set up the ole' put the slip to maumee game this time....I'm on to ya now!!LOL
Posts: 3209 | From: poohville ohio | Registered: Apr 2005
| IP: Logged |
9 Nigerian Banks Make World Top Banks Soludo not a member of the Economic Team By Samuel Famakinwa in Lagos and Kunle Aderinokun in Abuja, 07.03.2006
The just concluded consolidation exercise in the Nigerian banking sector has again reaped another benefit as nine Nigerian banks have made it into the listing of Top 1000 World Banks, up from four in 2005. Indication also emerged at the weekend that the Central Bank of Nigeria (CBN) may drag the Revenue Mobilisation, Allocation and Fiscal Commis-sion (RMAFC) to court over claims on withdrawals from the foreign reserves. The Banker Magazine, an arm of the Financial Times Group weekend released its world renowned Top 1000 World Banks ranking for 2006 and on the list were First Bank, Union Bank, Zenith Interna-tional Bank, IBTC Chartered Bank, Intercontinental Bank, Spring Bank, GT Bank, First Inland and Oceanic Bank. According to the magazine, the rise in the number of Nigerian banks in this global 1,000 listing is “due to the consolidation that has taken place in the banking sector in Nigeria since 1st January 2006 and the creation of larger banking institutions with a minimum capital requirement of N25 billion”. The rankings, the magazine said, are based on Tier 1 Capital as defined by Basel’s Bank for International Settlements (BIS), a definition which is stricter than total shareholders’ equity and covers only the core of the bank’s strength, that is, shareholders’equity available to cover actual or potential losses. Tier 1 includes common stock, disclosed reserves and retained earnings and, in the case of consolidated accounts, minority interests in the equity of subsidiaries that are less than wholly owned. However, it excludes cumulative preference shares, revaluation reserves, hidden reserves, subordinated and other long term debt. In the order of ranking First Bank topped the Nigerian banks with 784 position and closely followed by Union Bank ranked 797. Others are Zenith Bank 857, IBTC Chartered Bank 863, Intercontinental Bank 877, Spring Bank 888, GT Bank 918, First Inland 975 and Oceanic Bank 995. The magazine noted that this year banks from around the world needed $216m of Tier 1 Capital to make it into our Top 1000 ranking and figures are either used from annual reports or from a returned questionaire. However, it said 2007 should provide a more complete picture of which Nigerian banks make it into the Top 1000 as year-end figures become available for the newly consolidated banks. Overall, it added that the increase represents a positive outlook for the Nigerian banking sector with larger banks providing a better platform for economic development. The Top 1000 World Banks is a ranking of the world’s commercial banks and wherever possible, consolidated figures have been taken for the banking group. However, in the case of bancassurance groups, where possible, the figures reflect the banking business only. In a statement released at the weekend, The Bankers magazine said the “object of the survey is to show the banks’ soundness in relation to the Basel requirement of a minimum Tier 1 capital on risk-weighted assets of 4 per cent, and a minimum ratio of capital to risk-weighted assets of 8 per cent.” “The published assets figures differ from the risk-weighted assets figures that are used to calculate BIS ratios. Weights applied range from zero (to assets such as cash, claims on central banks and governments in local currency), to 20 per cent (to assets such as lending to multilateral development banks), to 50 per cent (to residential mortgages) to 100 per cent (to private-sector lending, non-OECD lending and so on). However, the Basel rules adopted by individual countries’ regulatory authorities will vary to some extent. “Wherever possible, the total assets figures shown exclude third-party items such as acceptances, guarantees and securities held with third parties. “Pre-tax profits are used to show banks’ performance and the figures for real profit growth take inflation into account. The profit-on-capital ratios are calculated using the average of the latest and previous years’ capital figures. “The NPL column refers to the gross non-performing loans as a percentage of the total loan book. This year, we have excluded all banks whose latest figures were prior to December 31, 2003, even though they may still be operating”, the statement reads. Meanwhile, indication emerged at the weekend that the Central Bank of Nigeria (CBN) may drag the Revenue Mobilisation, Allocation and Fiscal Commission (RMAFC) to court over claims on withdrawals from the foreign reserves. THISDAY gathered that a group of senior officials of the apex bank were pressing its Legal department on the possibility of seeking redress in the law court with its sister organ of government. The development is coming ahead of further probe into the allegation of tampering with the nation’s burgeoning external reserves leveled against the CBN and the Ministry of Finance by the Revenue Commission when the Senate resumes in August for its fourth session. Chairman of RMAFC, Eng. Hamman Tukur, had last month told Senators, amongst others that gathered at the Public Hearing called by the Senate, that the amount in the nation’s foreign reserves stood at $12.5 billion as at the end of May, which contradicted the record of $34.09 billion given by the CBN, implying that the bank was lying. He had also said operation of the excess crude account was illegal and also considered illegal withdrawal from the foreign reserve account. This may have drawn the ire of the bank’s senior officials who are now bent on proving CBN’s innocence in the law court. It could be recalled that, shortly after the debate on the constitution review, which major highlight was the Third Term, Senator Farouk Bello Bunza sparked off a controversy when he said the foreign reserve had been reduced to $9.9 billion and that monies were withdrawn from the account without the consent of the Senate. According to sources, the apex bank’s officials were insisting that the commission committed a slander by saying that the level of reserves was much less than the former as “billions have been withdrawn from the account secretly and illegally. CBN source nonetheless told THISDAY last night that the school of thought angling for a legal redress only wanted to ensure that no individual or group would in future seek to discredit the bank simply for political reasons. The source accused Tukur of playing “cheap politics” in his presentation to the Senate Committees at the last month’s public hearing noting that both the international community and the market knew who was saying the truth. “How did the market react to the allegation? If they took him seriously, we would have witnessed a free fall of the naira at the foreign exchange market”, he pointed out. However, RMAFC’s official who spoke on the condition anonymity said the matter to be resolved remained whether or not the Excess Crude Account ought to be regarded as part of the foreign reserve or not stressing that, “in any case, what we are saying is that billions of dollars was secretly withdrawn from the excess crude account, without the consent of the National Assembly.” Meanwhile, contrary to yesterday's report which listed the Central Bank Governor, Prof. Charles Soludo, among members of the economic management team in the Obasanjo administration who have constituted themselves into a pressure group which is seeking to ensure that none of the old names in the presidential race emerged as the next occupant of Aso Rock in 2007, he is not a member. Operating under the pseudo name of the 'The Reformists', a name derived from the economic reforms policy of the administration, members of the group, sources said, have after several meetings concluded that "what is needed in the election of a new President is not power shift but a complete paradigm shift.” But THISDAY checks reveal that Soludo is neither a member of the group nor does he seek or play any political role, concentrating solely on his job as CBN Governor.
-------------------- Buy Low. Sell High. Posts: 10750 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
posted
This puppy is maken it hard to play the "Pick the close and volume" game now,isn't it??hehehe
Posts: 3209 | From: poohville ohio | Registered: Apr 2005
| IP: Logged |
posted
guys, check out the screeners in ( multi bagger dot com) it lets me search for stocks that are 4 consecutive trading days down ..
Posts: 27 | Registered: Jun 2006
| IP: Logged |
quote:Originally posted by amswap: Good article. They say this is a natural herbal pill. If that's the case, then why would we need FDA or any other approval? Did I scan too fast and miss something?
If you make drug-like claims the FDA will step in and inspect the product, pulling it from shelves if it were already on the market. So since they claim it works to cure/treat disease, they are speaking in drug-like terms.
Supplements have disclaimers about not being intended to treat anything.
Posts: 718 | From: Bay Area, CA | Registered: Aug 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
Even though the cops stop every once in a while and ask what the hell you are doing on the side of the road.![[Big Grin]](biggrin.gif)
GOOD LUCK GUYS! check out FHAL too!
